JP2002308895A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002308895A5 JP2002308895A5 JP2002026232A JP2002026232A JP2002308895A5 JP 2002308895 A5 JP2002308895 A5 JP 2002308895A5 JP 2002026232 A JP2002026232 A JP 2002026232A JP 2002026232 A JP2002026232 A JP 2002026232A JP 2002308895 A5 JP2002308895 A5 JP 2002308895A5
- Authority
- JP
- Japan
- Prior art keywords
- angstroms
- rays
- irradiation
- wavelength
- copper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013078 crystal Substances 0.000 claims 5
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 4
- 229910052802 copper Inorganic materials 0.000 claims 4
- 239000010949 copper Substances 0.000 claims 4
- 238000000634 powder X-ray diffraction Methods 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 2
- 238000002425 crystallisation Methods 0.000 claims 2
- 230000008025 crystallization Effects 0.000 claims 2
- 239000002246 antineoplastic agent Substances 0.000 claims 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002026232A JP3748536B2 (ja) | 2001-02-09 | 2002-02-04 | ピリミジンヌクレオシド誘導体の結晶 |
| US10/637,300 US6908906B2 (en) | 2001-02-09 | 2003-08-07 | Crystalline forms of pyrimidine nucleoside derivative |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001-33128 | 2001-02-09 | ||
| JP2001033128 | 2001-02-09 | ||
| JP2002026232A JP3748536B2 (ja) | 2001-02-09 | 2002-02-04 | ピリミジンヌクレオシド誘導体の結晶 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005230800A Division JP4356998B2 (ja) | 2001-02-09 | 2005-08-09 | ピリミジンヌクレオシド誘導体の結晶を含有する医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002308895A JP2002308895A (ja) | 2002-10-23 |
| JP2002308895A5 true JP2002308895A5 (cg-RX-API-DMAC7.html) | 2005-08-18 |
| JP3748536B2 JP3748536B2 (ja) | 2006-02-22 |
Family
ID=18896929
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002026232A Expired - Lifetime JP3748536B2 (ja) | 2001-02-09 | 2002-02-04 | ピリミジンヌクレオシド誘導体の結晶 |
| JP2005230800A Expired - Lifetime JP4356998B2 (ja) | 2001-02-09 | 2005-08-09 | ピリミジンヌクレオシド誘導体の結晶を含有する医薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005230800A Expired - Lifetime JP4356998B2 (ja) | 2001-02-09 | 2005-08-09 | ピリミジンヌクレオシド誘導体の結晶を含有する医薬 |
Country Status (21)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2081419B1 (en) | 1999-09-02 | 2013-08-07 | Ibiden Co., Ltd. | Printed circuit board and method of manufacturing printed circuit board |
| CN101232776B (zh) | 1999-09-02 | 2011-04-20 | 揖斐电株式会社 | 印刷布线板 |
| GB0526419D0 (en) | 2005-12-23 | 2006-02-08 | Cyclacel Ltd | Formulation |
| GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
| JP5066737B2 (ja) * | 2007-04-06 | 2012-11-07 | 大鵬薬品工業株式会社 | シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤 |
| US8124593B2 (en) | 2007-11-05 | 2012-02-28 | Cyclacel Limited | Methods of treatment using sapacitabine |
| GB0808357D0 (en) * | 2008-05-08 | 2008-06-18 | Cyclacel Ltd | Process |
| PL2307002T3 (pl) | 2008-06-09 | 2013-05-31 | Cyclacel Ltd | Kombinacje sapacytabiny lub cndac z inhibitorami metylotransferazy dna, takimi jak decytabina i prokaina |
| PL2696878T3 (pl) | 2011-04-14 | 2020-01-31 | Cyclacel Limited | Schemat dawkowania dla sapacytabiny i decytabiny w kombinacji do leczenia ostrej białaczki szpikowej |
| ES2880109T3 (es) | 2012-03-15 | 2021-11-23 | Celgene Car Llc | Formas sólidas de un inhibidor de la cinasa del receptor del factor de crecimiento epidérmico |
| ES2963057T3 (es) * | 2015-03-09 | 2024-03-25 | Grace W R & Co | Forma cristalina de ribósido de nicotinamida |
| EP3727400A4 (en) | 2017-12-22 | 2021-10-20 | Elysium Health, Inc. | CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2559917B2 (ja) * | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
| FI105556B (fi) * | 1991-09-30 | 2000-09-15 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta |
-
2002
- 2002-02-04 JP JP2002026232A patent/JP3748536B2/ja not_active Expired - Lifetime
- 2002-02-06 CN CNB028079337A patent/CN100408591C/zh not_active Expired - Lifetime
- 2002-02-06 EP EP02711347A patent/EP1364959B1/en not_active Expired - Lifetime
- 2002-02-06 KR KR1020037010308A patent/KR100679904B1/ko not_active Expired - Lifetime
- 2002-02-06 CZ CZ20032111A patent/CZ303241B6/cs not_active IP Right Cessation
- 2002-02-06 DK DK02711347T patent/DK1364959T3/da active
- 2002-02-06 AU AU2002230164A patent/AU2002230164B2/en not_active Expired
- 2002-02-06 PT PT02711347T patent/PT1364959E/pt unknown
- 2002-02-06 BR BRPI0207102A patent/BRPI0207102A8/pt unknown
- 2002-02-06 IL IL15721602A patent/IL157216A0/xx active IP Right Grant
- 2002-02-06 MX MXPA03007123A patent/MXPA03007123A/es active IP Right Grant
- 2002-02-06 WO PCT/JP2002/000986 patent/WO2002064609A1/ja not_active Ceased
- 2002-02-06 BR BR0207102-9A patent/BR0207102A/pt not_active Application Discontinuation
- 2002-02-06 NZ NZ527393A patent/NZ527393A/en not_active IP Right Cessation
- 2002-02-06 HU HU0303159A patent/HU229294B1/hu unknown
- 2002-02-06 DE DE60220024T patent/DE60220024T2/de not_active Expired - Lifetime
- 2002-02-06 AT AT02711347T patent/ATE361929T1/de active
- 2002-02-06 ES ES02711347T patent/ES2286237T3/es not_active Expired - Lifetime
- 2002-02-06 CA CA2437994A patent/CA2437994C/en not_active Expired - Lifetime
- 2002-02-06 RU RU2003124648/04A patent/RU2256666C2/ru active
-
2003
- 2003-08-04 IL IL157216A patent/IL157216A/en unknown
- 2003-08-07 ZA ZA2003/06121A patent/ZA200306121B/en unknown
-
2005
- 2005-08-09 JP JP2005230800A patent/JP4356998B2/ja not_active Expired - Lifetime
-
2007
- 2007-07-02 CY CY20071100860T patent/CY1106685T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023145481A5 (cg-RX-API-DMAC7.html) | ||
| JP2018024682A5 (cg-RX-API-DMAC7.html) | ||
| JP2013538253A5 (cg-RX-API-DMAC7.html) | ||
| JP2011168587A5 (cg-RX-API-DMAC7.html) | ||
| JP2020511467A5 (cg-RX-API-DMAC7.html) | ||
| RU2012138892A (ru) | СОЛИ И ПОЛИМОРФЫ 8-ФТОР-2-{4-[(МЕТИЛАМИНО)МЕТИЛ]ФЕНИЛ}-1,3,4,5,-ТЕТРАГИДРО-6Н-АЗЕПИНО[5,4,3-cd]ИНДОЛ-6-ОНА | |
| JP2004524889A5 (cg-RX-API-DMAC7.html) | ||
| JP2005527336A5 (cg-RX-API-DMAC7.html) | ||
| JP2004188187A5 (cg-RX-API-DMAC7.html) | ||
| JP2009502743A5 (cg-RX-API-DMAC7.html) | ||
| JP2005526058A5 (cg-RX-API-DMAC7.html) | ||
| UY29407A1 (es) | Forma cristalina gamma-d del clorhidrato de ivabradina, su procedimiento de preparación y composiciones farmaceuticas que la contienen. | |
| AR029571A1 (es) | Nueva forma cristalina beta de la sal de terbutilamina de perindopril, procedimiento para su preparacion y composiciones farmaceuticas que la contienen | |
| ATE520406T1 (de) | Kristalline form des ibandronat-natriums | |
| RU2222544C1 (ru) | Кристалл производного аспартама | |
| JP2007191765A5 (cg-RX-API-DMAC7.html) | ||
| CA2522486A1 (en) | Bromide and crystals thereof | |
| JP2004510683A5 (cg-RX-API-DMAC7.html) | ||
| JP2006502115A5 (cg-RX-API-DMAC7.html) | ||
| RU99104300A (ru) | Кристаллическая модификация фармацевтического агента | |
| CU23200A3 (es) | Sal polimorfica | |
| CA2437994A1 (en) | Crystalline forms of pyrimidine nucleoside derivative | |
| PE20090192A1 (es) | Sal citrato de 2-hidroxi-3-[5-(morfolin-4-ilmetil)piridin-2-il]1h-indol-5-carbonitrilo | |
| TW200628474A (en) | Organic compounds | |
| JP2005505571A5 (cg-RX-API-DMAC7.html) |